CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-11 | Kingsley Lawrence D Director | Option exercise · Restricted Stock Unit | −120 | 0 | ||
| 2023-05-11 | ESSIG STUART Director | Option exercise | +344 | 1,717 | ||
| 2023-05-11 | ESSIG STUART Director | Option exercise · Restricted Stock Unit | −344 | 0 | ||
| 2023-05-11 | COLLINS Asha Director | Option exercise | +344 | 522 | ||
| 2023-05-11 | COLLINS Asha Director | Option exercise · Restricted Stock Unit | −344 | 0 | ||
| 2023-05-11 | AYERS JONATHAN W Director | Option exercise | −1,685 | 140,209 | ||
| 2023-05-11 | AYERS JONATHAN W Director | Option exercise | +344 | 140,553 | ||
| 2023-05-11 | AYERS JONATHAN W Director | Option exercise · Restricted Stock Unit | −344 | 0 | ||
| 2023-05-10 | AYERS JONATHAN W Director | Option exercise | +560 | $178.26 | $100K | 141,894 |
| 2023-05-10 | AYERS JONATHAN W Director | Option exercise · Incentive Stock Option (right-to-buy) | −560 | 0 | ||
| 2023-05-09 | AYERS JONATHAN W Director | Gift | −1,685 | 141,334 | ||
| 2023-05-05 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise | +483 | $206.94 | $100K | 4,244.7 |
| 2023-05-05 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise · Common Stock | −483 | 483 | ||
| 2023-05-05 | SZOSTAK M ANNE Director | Sale | −700 | $473.59 | $332K | 6,000 |
| 2023-05-05 | SZOSTAK M ANNE Director | Sale | −800 | $475.27 | $380K | 5,200 |
| 2023-05-05 | SZOSTAK M ANNE Director | Sale | −500 | $476.12 | $238K | 4,700 |
| 2023-05-05 | MCKEON BRIAN P EVP, CFO and Treasurer | Option exercise | +560 | $178.26 | $100K | 29,605.35 |
| 2023-05-05 | MCKEON BRIAN P EVP, CFO and Treasurer | Option exercise · Incentive Stock Option (right-to-buy) | −560 | 0 | ||
| 2023-05-05 | Lane Michael Executive Vice President | Sale | −1,000 | $484.00 | $484K | 4,021.99 |
| 2023-05-05 | AYERS JONATHAN W Director | Gift | −2,500 | 143,019 |
Page 44 of 52 · 1,036 trades